登录新浪财经APP 搜索【信披】查看更多考评等级 5、公司将依据相关规定，及时做好信息披露工作，并在定期报告中披露报告期内使用闲置资金进行现 金管理的具体情况。 公司本次使用部分闲置自有资金进行现金管理，仅投资于安全性高、流动性好的短期保本或稳健型理财 产品，投资风险可控；但金融市场受宏观经济、市场波动的影响，不排除投资收益具有一定的不可预期 性。敬请广大投资者谨慎决策，注意防范投资风险。 五、决策程序的履行情况 公司于2025年4月24日召开第五届董事会第十八次会议、第五届监事会第十二次会议，分别审议通过了 《关于使用部分闲置自有资金进行现金管理的议案》；同意自股东大会审议通过之日起12个月内，在保 证正常经营所需流动资金的情况下，使用不超过人民币6.5亿元暂时闲置自有资金进行现金管理；在上 述额度内，该类资金可以单笔或分笔进行单次或累计滚动不超过一年期的现金管理，并授权由公司法定 代表人或其授权人员行使投资决策职责和具体实施。 该议案尚需提交股东大会审议通过。 特此公告 三、对公司的影响 1、公司本次使用部分闲置自有资金进行现金管理，是在确保公司日常经营和资金安全的前提下实施 的，不影响日常经营资金的正常 ...

2025 年 04 月 14 日 行业研究 评级：推荐(维持) 证券分析师： 程一胜 S0350521070001 chengys01@ghzq.com.cn [Table_Title] 关注贸易冲突背景下粮食安全 ——农林牧渔行业周报 最近一年走势 | 行业相对表现 | | 2025/04/11 | | | --- | --- | --- | --- | | 表现 | 1M | 3M | 12M | | 农林牧渔 | 5.1% | 12.8% | 0.2% | | 沪深 300 | -4.8% | 0.5% | 7.0% | 相关报告 《农林牧渔行业周报：养殖底部布局（推荐）*农 林牧渔*程一胜，熊子兴，王思言》——2025-03-24 《农林牧渔行业周报：贸易摩擦格局下，农业板块 配置思路分析（推荐）*农林牧渔*程一胜，熊子兴， 王思言》——2025-03-10 《农林牧渔行业周报：粮价回升，宠物线上品牌延 续高景气（推荐）*农林牧渔*程一胜，熊子兴，王 思言》——2025-02-24 《农林牧渔行业周报：玉米豆粕反弹，春节后猪价 走弱（推荐）*农林牧渔*程一胜，熊子兴，王思言》 ——2025-02-10 ...

点击注册小程序 查看完整报告 特别申明： 公司2024年实现营业收入30.7亿元，同比+36.5%，实现归母净利润3.01亿元，同比-33.61%，扣非归母净 利润2.81亿元，同比-11.87%。 全年营收稳健增长，利润短期承压 2024年营收增长稳健，主要受益于兽用生物制品和宠物供应链，同比+23.4%和+37.66%。分产品营收增减 情况各异，制剂及原料药营收同比-5.83%，宠物药品营收同比-28.26%；宠物生物制品、畜用生物制品、 宠物供应链、禽用生物制品营收显著上升，同比+849.09%、+49.78%、+37.66%、+15.9%。利润方面，受 市场价格波动和原料成本上涨影响，公司整体毛利率从23年的49.69%降至41.38%。 扩大研发创新投入，补强战略产业结构 本订阅号中所涉及的证券研究信息由光大证券研究所编写，仅面向光大证券专业投资者客户，用作新媒体形势下研究 信息和研究观点的沟通交流。非光大证券专业投资者客户，请勿订阅、接收或使用本订阅号中的任何信息。本订阅号 难以设置访问权限，若给您造成不便，敬请谅解。光大证券研究所不会因关注、收到或阅读本订阅号推送内容而视相 关人员为光大证券的客 ...

Core Viewpoint - The internal control evaluation report of Reap Bio Co., Ltd. indicates that there are no significant defects in both financial and non-financial reporting internal controls as of the evaluation date, affirming the effectiveness of the company's internal control system [2][14]. Internal Control Objectives - The objectives of the internal control system include ensuring legal compliance in management, safeguarding assets, ensuring the accuracy of financial reporting, improving operational efficiency, and supporting the achievement of strategic goals [2]. Internal Control Evaluation Conclusion - The board of directors confirms that there are no significant defects in financial reporting internal controls and non-financial reporting internal controls as of the evaluation date [2][14]. Internal Control Evaluation Scope - The evaluation covers the company and its wholly-owned and controlled subsidiaries, which account for 100% of total assets and total revenue in the consolidated financial statements [3]. High-Risk Areas - Key high-risk areas evaluated include procurement, sales, engineering activities, fundraising management, human resources, financial activities, asset management, financial reporting, contract management, and information disclosure [3][4]. Procurement Management - The company has established a dedicated supplier development department to manage procurement, adhering to veterinary drug production quality management standards and implementing a comprehensive procurement management system [4]. Sales Management - A complete sales system and process have been established, including credit risk management and a closed-loop management system for sales-related activities to ensure financial safety and improve capital turnover efficiency [5]. Engineering Management - The company has developed an integrated engineering management system that outlines project approval processes, responsibilities, and construction management to enhance project oversight [6]. Fundraising Management - The company has detailed regulations for the management of raised funds, ensuring proper storage, usage, and disclosure, with funds managed in designated accounts [6]. Human Resources Management - The company emphasizes sustainable development in human resources, focusing on ethical standards and professional capabilities in employee selection and training [7]. Financial Activities Management - The company has revised its fund management system to ensure strict control over monetary funds, with clear approval processes and budget management [8]. Asset Management - The company follows a physical asset management system, assigning responsibility for asset management and conducting regular checks to ensure asset safety [9]. Financial Reporting Management - The finance department prepares financial reports in accordance with relevant laws and regulations, ensuring accurate and timely reporting [9]. Contract Management - The company has established a legal review department to oversee contract management processes, ensuring compliance and risk mitigation [10]. Information Disclosure Management - The company has developed internal control systems for information disclosure to ensure the accuracy and completeness of disclosed information, enhancing communication with investors [11].